Idiopathic gout, unspecified site
Methodology & AI Transparency ⓘ
Idiopathic gout, unspecified site Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Idiopathic gout, unspecified site—coded clinically as M10.00 across Arthritis & Joints guidelines—combines weight-bearing joint radiography [Idiopathic gout, unspecified site M10.00] with structured follow-up of Weight-Bearing Joint Radiograph [Idiopathic gout, unspecified site M10.00] (Preserved joint-space width (M10.00)).
- 2 Real-world patient consensus: Diagnostic registry M10.00: Idiopathic gout, unspecified site is managed within Arthritis & Joints.
- 3 Typical cash cost range: Primary evaluation for Idiopathic gout, unspecified site incorporates weight-bearing joint radiography [Idiopathic gout, unspecified site M10.00] and symptom diary review.
- 4 Top reported side effects / signs: Longitudinal Idiopathic gout, unspecified site monitoring tracks hs-CRP & Erythrocyte in Idiopathic gout, unspecified site (M10.00: Sedimentation Rate) toward hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M10.00).
Ask our AI Specialists anything about Idiopathic gout, unspecified site
What Is Idiopathic gout, unspecified site?
Idiopathic gout, unspecified site—coded clinically as M10.00 across Arthritis & Joints guidelines—combines weight-bearing joint radiography [Idiopathic gout, unspecified site M10.00] with structured follow-up of Weight-Bearing Joint Radiograph [Idiopathic gout, unspecified site M10.00] (Preserved joint-space width (M10.00)).
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Idiopathic gout, unspecified site (M10.00) center on monosodium urate or in Idiopathic gout, unspecified site (M10.00: calcium pyrophosphate crystal). targeted arthritis & joints interventions aim to normalize hs-CRP & Erythrocyte in Idiopathic gout, unspecified site (M10.00: Sedimentation Rate).
Common Symptoms & Clinical Signs
- • Presentation of Idiopathic gout, unspecified site (M10.00): brief morning joint in Idiopathic gout, unspecified site (M10.00: stiffness)
- • Secondary Idiopathic gout, unspecified site clinical sign: sudden, intensely painful, in Idiopathic gout, unspecified site (M10.00: red swollen big-toe)
- • Symptom flares in Idiopathic gout, unspecified site correlating with hs-CRP & Erythrocyte in Idiopathic gout, unspecified site (M10.00: Sedimentation Rate) deviation outside hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M10.00)
- • Functional arthritis & joints impact requiring weight-bearing joint radiography [Idiopathic gout, unspecified site M10.00] evaluation (M10.00)
Idiopathic gout, unspecified site Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | M10.00 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Osteoarthritis, Gout & Joint Pain | NLM Clinical Tables |
| Diagnostic / Lab Marker: hs-CRP & Erythrocyte in Idiopathic gout, unspecified site (M10.00: Sedimentation Rate) | hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M10.00) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Weight-Bearing Joint Radiograph [Idiopathic gout, unspecified site M10.00] | Preserved joint-space width (M10.00) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Uric Acid in Idiopathic gout, unspecified site (M10.00: (Gout Target)) | < 6.0 mg/dL (< 5.0 mg/dL with tophi) (M10.00) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Idiopathic gout, unspecified site
Treatment selection for Idiopathic gout, unspecified site depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Idiopathic gout, unspecified site)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic: What a 2,639-Participant Study Found Overall (N = 2,639; 3 mg of plecanatide [n = 877]; 6 mg of plecanatide [n = 877]; and placebo [n = 885]), CSBM responder rates were significantly greater with 3 mg of plecanatide and 6 mg of plecanatide vs placebo in subgroups... Clinical and translational gastroenterology • 2023-07-01 • Phase III Randomized Trial | N = 2,639 | 96/100 | PMID 37162147 ↗ |
| New Insights on Apremilast single-drug treatment for long-term treatment of active psoriatic: What a 527-Participant Study Found Apremilast led to sustained PsA efficacy up to 260 weeks and was well tolerated. Rheumatology (Oxford, England) • 2022-03-02 • Phase III Randomized Trial | N = 527 | 93/100 | PMID 34100922 ↗ |
| New Insights on Serum biomarkers associated with baricitinib response in patients with juvenile: What a 220-Participant Study Found To our knowledge, this is the first study measuring serum protein markers in the context of an intervention trial with baricitinib in patients with JIA. The Lancet. Rheumatology • 2025-11-15 • Phase III Randomized Trial | N = 220 | 88/100 | PMID 40915298 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits of finasteride for hirsute women with polycystic ovary syndrome or All the patients treated with finasteride perceived a reduction in hirsutism after 6 months. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology • 2003-02-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 12724020 ↗ |
| Can This Approach Help? Inside the Latest Research on Low-sodium oxybate on diary-based sleep time in a clinical study in adults with Open-label LXB treatment in adults with idiopathic hypersomnia was associated with reductions in 24-hour TST, nocturnal TST, and total nap duration. Sleep medicine • 2026-02-15 • Phase III Randomized Trial | N = 148 | 88/100 | PMID 41442817 ↗ |
Idiopathic gout, unspecified site Patient Community & “People Like Me” Threads
Filter Idiopathic gout, unspecified site community threads and patient logs by age, biological sex, dosage, and treatment duration.